Literature DB >> 15103259

Gout.

Eliseo Pascual1, Teresa Pedraz.   

Abstract

PURPOSE OF THE REVIEW: We have reviewed the latest publications on epidemiology of gout; also there have been new insights into the regulation of the inflammation resulting from the regular interaction occurring between MSU crystals and cells in both asymptomatic and symptomatic gouty joints. Finally we review different publications of clinical interest. RECENT
FINDINGS: The incidence of gout has been found to be increasing, and the disease starts at an earlier age; this likely relates to changes in dietary habits that lead to the development of the insulin resistance syndrome to which hyperuricemia, and thus gout, relates. Dietary modifications to correct the insulin resistance syndrome and reduce uricemia by increasing renal clearance of urate have heath consequences that go far beyond their beneficial effect on gout. Monosodium urate crystals and cells interact in the asymptomatic joints of gouty patients. The mechanisms that trigger a gouty attack with this background and those responsible for the self-limitation of gouty attacks are not understood. The degree of maturation of the monocytes-macrophages present in the fluid appears to modulate the consequences of the crystal-cell interaction and gives a hint of how from the crystal-cell interaction may result in such divergent consequences as intense inflammation or the absence of symptoms. Interest in gout treatment continues, as shown by the number of papers on the subject reviewed. In most cases, gout is an easy disease to treat, but we do not have enough information about how to handle those few patients with "difficult" disease, and what we refer colloquially to as difficult gout has not been properly defined yet.
SUMMARY: Gout incidence and severity appear to be increasing likely in relation to dietary habits. Switching the pattern of secretion of inflammatory mediators with maturating macrophages which contain MSU crystals may be the key to self limitation of gouty attacks. We must define better which gout is a "difficult" one.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103259     DOI: 10.1097/00002281-200405000-00020

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  4 in total

1.  Recombinant production of Aspergillus Flavus uricase and investigation of its thermal stability in the presence of raffinose and lactose.

Authors:  Mehdi Imani; Serveh Shahmohamadnejad
Journal:  3 Biotech       Date:  2017-06-30       Impact factor: 2.406

2.  MicroRNA-142-3p facilitates inflammatory response by targeting ZEB2 and activating NF-κB signaling in gouty arthritis.

Authors:  Yao Lu; Li Fang; Xiangfeng Xu; Yanying Wu; Jiajia Li
Journal:  Cell Cycle       Date:  2022-03-03       Impact factor: 5.173

3.  Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response.

Authors:  Jamie Marie Orengo; Aleksandra Leliwa-Sytek; James E Evans; Barbara Evans; Diana van de Hoef; Marian Nyako; Karen Day; Ana Rodriguez
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

4.  Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.

Authors:  Klaus Stark; Wibke Reinhard; Katharina Neureuther; Silke Wiedmann; Kamil Sedlacek; Andrea Baessler; Marcus Fischer; Stefan Weber; Bernhard Kaess; Jeanette Erdmann; Heribert Schunkert; Christian Hengstenberg
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.